Please login to the form below

Not currently logged in
Email:
Password:

South Africa to develop HIV, TB and malaria vaccines

South Africa's President, Thabo Mbeki, opens the third branch of the International Centre for Genetic Engineering and Biotechnology in Cape Town

South Africa's President, Thabo Mbeki, has opened the third branch of the International Centre for Genetic Engineering and Biotechnology (ICGEB) in Cape Town, according to local media reports.

The centre will conduct vaccine R&D for HIV, malaria, tuberculosis and other infectious diseases affecting the country.

South Africa has spent ZAR 40m (USD 5.6m) on the ICGEB lab, which is located at the University of Cape Town's Institute of Infectious Diseases and Molecular Medicine.

As South Africa's funds were only sufficient to establish three research groups, President Mbeki challenged the international community to donate up to ZAR 120m (USD 17m), which would help to fund seven research programmes slated for a 2010 launch.

Mbeki also invited potential partners to assist and work with the ICGEB to ensure that it realised its objectives.

Nigeria and Tanzania lost out in competitive bids to host the African branch of ICGEB. The other ICGEB sites are located in Trieste, Italy, and New Delhi, India.

30th September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...
Deal Watch January 2018
...
Emotional Intelligence and Blended Learning in Healthcare
...

Infographics